SujayAVoraMD
Radiation Oncology • Phoenix, AZChair of the Department of Radiation Oncology, Mayo Clinic in Phoenix, Arizona
Dr. Vora is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5881 E Mayo Blvd
Phoenix, AZ 85054
Summary
- Sujay A. Vora, M.D. is a radiation oncologist and both the residency program director and chair at Mayo Clinic Arizona’s Department of Radiation Oncology. He treats brain tumors, including low and high grade glioma, brain metastasis, acoustic neuroma, meningioma and pituitary adenomas. He also treats gynecologic cancers including endometrial, cervix and vulvar/vagina malignancies. His research interests include CNS malignancies and providing higher value care for his patients He is an assistant professor of Radiation Oncology at Mayo Clinic College of Medicine and Science. Dr. Vora received his medical degree at University of Pittsburgh and was chief resident at Tufts/Brown combined residency program. In 2012, U.S. News and World Report named him among the top doctors in America. U.S. News and World Report ranks Mayo Clinic Arizona the #1 hospital in the state.
Education & Training
Tufts Medical CenterResidency, Radiation Oncology, 1995 - 1999
Newton-Wellesley HospitalInternship, Internal Medicine, 1994 - 1995
University of Pittsburgh School of MedicineClass of 1994
Certifications & Licensure
AZ State Medical License 2000 - 2026
RI State Medical License 1999 - 2001- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- Top Doctors:Arizona State Castle Connolly, 2013
Clinical Trials
- Pre-Operative or Post-Operative Stereotactic Radiosurgery in Treating Patients With Operative Metastatic Brain Tumors Start of enrollment: 2018 Nov 19
- 18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy Start of enrollment: 2019 Mar 28
Publications & Presentations
PubMed
- Five-year outcomes of moderately hypofractionated proton therapy incorporating elective pelvic nodal irradiation for high-risk prostate cancer.Richard Choo, Kimberly Corbin, Kenneth Merrell, Bradley Stish, Thomas M Pisansky
International Journal of Radiation Oncology, Biology, Physics. 2024-12-11 - 1 citationsShort-course hypofractionated proton beam therapy, incorporatingF-DOPA PET and contrast-enhanced MRI targeting, for patients aged 65 years and older with newly diagnos...Sujay Vora, Deanna Pafundi, Molly Voss, Matthew Buras, Jonathan Ashman
The Lancet. Oncology. 2024-12-01 - Accurate patient alignment without unnecessary imaging using patient-specific 3D CT images synthesized from 2D kV images.Yuzhen Ding, Jason M Holmes, Hongying Feng, Baoxin Li, Lisa A McGee
Communications Medicine. 2024-11-21
Press Mentions
(VIDEO) Breakthrough in the Fight Against GlioblastomaDecember 16th, 2024
Surviving Cervical Cancer, Sharing Her StoryMarch 22nd, 2019- Clinical Trials: A Significant Part of Cancer CareMay 9th, 2024
Committees
- Vice-Chair, Executive Committee Radiation Oncology 2019 - Present
- Residency Program Director, Education 2013 - Present
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
